INOSITOL
General Information
Mainterm | INOSITOL |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 87-89-8 |
Regnum |
107.100 182.5370 184.1370 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 892 |
IUPAC Name | cyclohexane-1,2,3,4,5,6-hexol |
InChI | InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H |
InChI Key | CDAISMWEOUEBRE-UHFFFAOYSA-N |
Canonical SMILES | C1(C(C(C(C(C1O)O)O)O)O)O |
Molecular Formula | C6H12O6 |
Wikipedia | inositol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 180.156 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 0 |
Complexity | 104.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B g O A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A A A A A A G g A A C A A A C B S g g A I A A A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A B E A I A A A A A Q A A F A A A B A A H A Y A Q A A A A A A A A A A A A C A A A Q A A C A A A A A A A A A A A = = |
Topological Polar Surface Area | 121.0 |
Monoisotopic Mass | 180.063 |
Exact Mass | 180.063 |
XLogP3 | None |
XLogP3-AA | -3.7 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 12 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB- | 0.5194 |
Human Intestinal Absorption | HIA+ | 0.8654 |
Caco-2 Permeability | Caco2- | 0.5533 |
P-glycoprotein Substrate | Non-substrate | 0.7394 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9633 |
Non-inhibitor | 0.9901 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9282 |
Distribution | ||
Subcellular localization | Mitochondria | 0.6446 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8523 |
CYP450 2D6 Substrate | Non-substrate | 0.9081 |
CYP450 3A4 Substrate | Non-substrate | 0.7198 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8485 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9099 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9520 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9641 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8545 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9045 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9670 |
Non-inhibitor | 0.9701 | |
AMES Toxicity | Non AMES toxic | 0.7623 |
Carcinogens | Non-carcinogens | 0.8722 |
Fish Toxicity | Low FHMT | 0.6995 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6734 |
Honey Bee Toxicity | High HBT | 0.7528 |
Biodegradation | Ready biodegradable | 0.5644 |
Acute Oral Toxicity | III | 0.7240 |
Carcinogenicity (Three-class) | Non-required | 0.6467 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | 0.2871 | LogS |
Caco-2 Permeability | 0.1692 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.6459 | LD50, mol/kg |
Fish Toxicity | 1.9583 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -1.0710 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic oxygen compounds |
Class | Organooxygen compounds |
Subclass | Alcohols and polyols |
Intermediate Tree Nodes | Secondary alcohols |
Direct Parent | Cyclohexanols |
Alternative Parents | |
Molecular Framework | Aliphatic homomonocyclic compounds |
Substituents | Cyclohexanol - Sugar alcohol - Cyclitol or derivatives - Cyclic alcohol - Polyol - Hydrocarbon derivative - Aliphatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as cyclohexanols. These are compounds containing an alcohol group attached to a cyclohexane ring. |
From ClassyFire